Skip to main content

Table 1 Clinical and laboratory characteristics of 101 AEG patients associated with OS

From: Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction

Patient-related factors No. of patients (%) OS (months) [mean (95 % CI)] P values
Gender
 Male 80 (79.2) 42.3 (36.9–47.7) 0.343
 Female 21 (20.8) 48.5 (39.4–57.7)  
Age (years)
 <60 23 (22.8) 44.5 (34.9–54.1) 0.976
 ≥60 78 (77.2) 43.3 (38.9–48.3)  
BMI (kg/m2)
 <18.5 9 (8.9) 31.7 (18.8–14.6) 0.180
 ≥18.5 and <25 71 (70.3) 45.5 (40.0–51.1)  
 ≥25 21 (20.8) 41.4 (30.7–52.0)  
Hemoglobin (g/L)
 <120 41 (40.6) 38.4 (31.4–45.4) 0.029*
 ≥120 60 (59.4) 44.6 (41.0–53.4)  
Albumin (g/L)
 <40 27 (26.7) 35.7 (26.4–44.9) 0.036*
 ≥40 74 (73.3) 46.0 (38.9–48.3)  
Pre-albumin (g/L)
 <200 29 (28.7) 31.5 (23.6–39.3) <0.001*
 ≥200 72 (71.3) 48.0 (43.0–53.8)  
PNI
 <51 54 (53.5) 37.6 (31.0–44.2) 0.008*
 ≥51 47 (46.5) 50.5 (44.3–56.7)  
Tumor size (cm)    0.004*
 <5 64 (63.4) 48.3 (42.5–54.1)  
 ≥5 37 (36.6) 35.4 (28.0–42.8)  
Differentiation grade
 Poor 69 (68.3) 39.4 (33.5–45.3) 0.031*
 Well 32 (31.7) 52.0 (45.0–58.0)  
Tumor location
 Siewert II 6 (5.9) 40.3 (19.6–61.1) 0.923
 Siewert III 95 (5.1) 43.8 (38.9–48.6)  
T stage
 T1, T2 18 (17.8) 61.9 (56.2–67.6) 0.001*
 T3, T4 83 (82.2) 39.6 (34.4–44.9)  
N stage
 N0 41 (40.6) 51.1 (43.9–58.4) 0.001*
 N1 43 (42.6) 41.3 (34.7–47.9)  
 N2 16 (15.8) 32.5 (20.8–44.2)  
 N3 1 (1.0) 8.0 (8.0–8.0)  
TNM stage
 I, II 44 (43.6) 52.5 (45.7–59.2) <0.001*
 III, IV 57 (56.4) 36.7 (30.8–42.7)  
Surgical type
 Total gastrectomy 6 (5.9) 57.0 (42.7–71.3) 0.131
 Proximal gastrectomy 95 (94.1) 42.7 (37.8–47.6)  
  1. BMI body mass index, PNI prognostic nutritional index
  2. *P < 0.05